Cognition Therapeutics Stock Forward View - Accumulation Distribution
| CGTX Stock | USD 1.00 0.03 2.91% |
Cognition Stock outlook is based on your current time horizon.
At this time the rsi of Cognition Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.08) | EPS Estimate Current Year (0.39) | EPS Estimate Next Year (0.34) | Wall Street Target Price 3.5 | EPS Estimate Current Quarter (0.09) |
Using Cognition Therapeutics hype-based prediction, you can estimate the value of Cognition Therapeutics from the perspective of Cognition Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Cognition Relative Strength Index
Cognition Therapeutics Hype to Price Pattern
Investor biases related to Cognition Therapeutics' public news can be used to forecast risks associated with an investment in Cognition. The trend in average sentiment can be used to explain how an investor holding Cognition can time the market purely based on public headlines and social activities around Cognition Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cognition Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cognition Therapeutics.
Cognition Therapeutics after-hype prediction price | USD 0.95 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cognition | Build AI portfolio with Cognition Stock |
Cognition Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cognition price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cognition using various technical indicators. When you analyze Cognition charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 163053.0 | 98235.93 |
| Check Cognition Therapeutics Volatility | Backtest Cognition Therapeutics | Information Ratio |
Cognition Therapeutics Trading Date Momentum
| On February 05 2026 Cognition Therapeutics was traded for 1.00 at the closing time. The top price for the day was 1.08 and the lowest listed price was 0.98 . The trading volume for the day was 1.1 M. The trading history from February 5, 2026 did not affect price variability. The overall trading delta against the current closing price is 4.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Cognition Therapeutics to competition |
Other Forecasting Options for Cognition Therapeutics
For every potential investor in Cognition, whether a beginner or expert, Cognition Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cognition Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cognition. Basic forecasting techniques help filter out the noise by identifying Cognition Therapeutics' price trends.Cognition Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cognition Therapeutics stock to make a market-neutral strategy. Peer analysis of Cognition Therapeutics could also be used in its relative valuation, which is a method of valuing Cognition Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cognition Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Cognition Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cognition Therapeutics shares will generate the highest return on investment. By undertsting and applying Cognition Therapeutics stock market strength indicators, traders can identify Cognition Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 98235.93 | |||
| Daily Balance Of Power | (0.30) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 1.03 | |||
| Day Typical Price | 1.02 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.03) |
Cognition Therapeutics Risk Indicators
The analysis of Cognition Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cognition Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cognition stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.02 | |||
| Standard Deviation | 5.21 | |||
| Variance | 27.12 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cognition Therapeutics
The number of cover stories for Cognition Therapeutics depends on current market conditions and Cognition Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cognition Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cognition Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cognition Therapeutics Short Properties
Cognition Therapeutics' future price predictability will typically decrease when Cognition Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cognition Therapeutics often depends not only on the future outlook of the potential Cognition Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cognition Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.7 M | |
| Cash And Short Term Investments | 25 M |
Additional Tools for Cognition Stock Analysis
When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.